S. Bardak-ozcem and O. R. Sipahi, An updated approach to healthcare-associated meningitis, Expert. Rev. Anti. Infect. Ther, vol.12, pp.333-375, 2014.

D. Van-de-beek, J. M. Drake, and A. R. Tunkel, Nosocomial bacterial meningitis, N. Engl. J. Med, vol.362, pp.146-54, 2010.

O. R. Sipahi, A. Zeka, M. Ta?bakan, H. Pullukçu, B. Arda et al., Pooled analysis of 899 nosocomial meningitis episodes from Turkey, Turk, J. Med. Sci, vol.47, pp.29-33, 2017.

O. R. Sipahi, Economics of antibiotic resistance, Expert Rev. Anti. Infect. Ther, vol.6, pp.523-562, 2008.

M. S. Tasbakan, H. Pullukcu, O. R. Sipahi, M. I. Tasbakan, S. Aydemir et al., Is tigecycline a good choice in the treatment of multidrug-resistant Acinetobacter baumannii pneumonia?, J. Chemother, vol.23, pp.345-354, 2011.

J. A. Wadi, J. A. , and M. A. Rub, Multidrug resistant Acinetobacter nosocomial meningitis treated successfully with parenteral tigecycline, Ann. Saudi. Med, vol.27, pp.456-464, 2007.

E. E. Tutuncu, F. Kuscu, Y. Gurbuz, B. Ozturk, A. Haykir et al., Tigecycline use in two cases with multidrug-resistant Acinetobacter baumannii meningitis, Int J Infect. Dis, vol.14, issue.3, pp.224-230, 2010.

W. Y. Kim, J. Y. Moon, J. W. Huh, S. H. Choi, C. M. Lim et al., Comparable Efficacy of Tigecycline versus Colistin Therapy for Multidrug-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Pneumonia in Critically Ill Patients, PLoS One, vol.11, p.150642, 2016.

Y. C. Chuang, Y. C. Cheng, W. H. Sheng, H. Y. Sun, J. T. Wang et al., Effectiveness of tigecycline-based versus colistin-based therapy for treatment of pneumonia caused by multidrug-resistant

, Acinetobacter baumannii in a critical setting: a matched cohort analysis, BMC Infect. Dis, vol.14, p.102, 2014.

O. R. Sipahi, H. Kahraman, S. Mermer, H. Pullukcu, M. Tasbakan et al.,

S. Aydemir and . Ulusoy, Tigecycline in the management of post-neurosurgical spondylodiscitis: a review of eight cases, Int. J. Infect. Dis, vol.23, pp.16-25, 2014.

O. R. Sipahi, S. Bardak, T. Turhan, B. Arda, H. Pullukcu et al.,

M. Yurtseven, S. Zileli, and . Ulusoy, Linezolid in the treatment of methicillin-resistant staphylococcal postneurosurgical meningitis: a series of 17 cases. Scand, J. Infect. Dis, vol.43, pp.757-64, 2011.

U. J. Kim, H. K. Kim, J. H. An, S. K. Cho, K. H. Park et al., Update on the Epidemiology, Treatment, and Outcomes of Carbapenem-resistant Acinetobacter infections, Chonnam. Med. J, vol.50, pp.37-44, 2014.

C. Buke, O. R. Sipahi, T. Yurtseven, and M. Zileli, High dose of intrathecal netilmicin in the treatment of nosocomial Acinetobacter baumannii meningitis, J Infect, vol.51, pp.420-422, 2005.

B. N. Kim, A. Y. Peleg, T. P. Lodise, J. Lipman, R. Li et al., Management of meningitis due to antibiotic-resistant Acinetobacter species, Lancet Infect .Dis, vol.9, pp.245-55, 2009.

H. B. Kooli, M. Brahim, C. Kilani, A. Gannouni, A. Aouam et al.,

. Chakroun, Successful treatment of postoperative multidrug-resistant Acinetobacter baumannii meningitis by tigecycline, J. Glob. Antimicrob. Resist, vol.5, pp.62-65, 2016.

G. D. Fang, W. J. Weiss, W. J. , and W. M. Scheld, Comparative efficacy of GAR-936, a novel glycylcycline, alone and in combination with vancomycin against highly penicillin-resistant Streptococcus pneumoniae experimental meningitis in rabbits, Abstracts of the fortieth Interscience Conference on Antimicrobials and Chemotherapy

. Toronto, . Ontario, and . Canada, , vol.868, p.51, 2000.

D. Yahav, A. Lador, M. Paul, M. , and L. Leibovici, Efficacy and safety of tigecycline: a systematic review and meta-analysis, J Antimicrob Chemother, vol.66, pp.1963-71, 2011.

P. C. Mcgovern, M. Wible, A. El-tahtawy, P. Biswas, and R. D. Meyer, All-cause mortality imbalance in the tigecycline phase 3 and 4 clinical trials, Int. J. Antimicrob. Agents, vol.41, pp.463-470, 2013.

J. Garner, APIC infection control and applied epidemiology: principles and practice, pp.1-20, 1996.

C. Pallotto, M. Fiorio, A. D'avolio, A. Sgrelli, F. Baldelli et al., Cerebrospinal fluid penetration of tigecycline. Scand, J. Infect. Dis, vol.46, pp.69-72, 2014.

C. Lengerke, M. Haap, F. Mayer, L. Kanz, M. Kinzig et al., Low tigecycline concentrations in the cerebrospinal fluid of a neutropenicpatient with inflamed meninges

, Antimicrob. Agents Chemother, vol.55, pp.449-50, 2011.

L. Lauretti, Q. G. D'alessandris, M. Fantoni, T. D'inzeo, E. Fernandez et al., First reported case of intraventricular tigecycline for meningitis from extremely drug-resistant Acinetobacter baumanni, J. Neurosurg, vol.127, pp.370-373, 2017.

Y. Wu, K. Chen, J. Zhao, Q. Wang, and . Zhou, Intraventricular administration of tigecycline for the treatment of multidrug-resistant bacterial meningitis after craniotomy: a case report, J. Chemother, vol.30, pp.49-52, 2017.

Y. Q. Fang, R. C. Zhan, W. Jia, B. Q. Zhang, and J. J. Wang, A case report of intraventricular tigecycline therapy for intracranial infection with extremely drug resistant Acinetobacter baumannii, Medicine

M. E. Falagas, I. A. Bliziotis, and I. A. Tam, Intraventricular or intrathecal use of polymyxins in patients with Gram-negative meningitis: a systematic review of the available evidence, Int. J. Antimicrob. Agents, vol.29, pp.9-25, 2007.

G. Fotakopoulos, D. Makris, M. Chatzi, E. Tsimitrea, E. Zakynthinos et al., Outcomes in meningitis/ventriculitis treated with intravenous or intraventricular plus intravenous colistin, Acta Neurochir. (Wien), vol.158, pp.603-613, 2016.

T. Khawcharoenporn, A. Apisarnthanarak, and L. M. Mundy,

, Acinetobacter baumannii central nervous system infection: a case series and systematic review, Clin. Microbiol. Infect, vol.16, pp.888-94, 2010.

G. A. March and M. A. Bratos, A meta-analysis of in vitro antibiotic synergy against Acinetobacter baumannii

, J. Microbiol. Methods, vol.119, pp.31-37, 2015.

J. C. Stoltzfus, Logistic regression: a brief primer, Acad. Emerg. Med, vol.18, pp.1099-104, 2011.

B. Ceylan, F. Arslan, O. R. Sipahi, M. Sunbul, B. Ormen et al.,